Carotid artery plaque characterization using CT multienergy imaging.

BACKGROUND AND PURPOSE: Carotid artery plaque types can be categorized with CT according to their HU values. The purpose of this work was to analyze carotid artery plaque characteristics by using multienergy imaging. METHODS AND MATERIALS: Thirty-two consecutive patients (23 men; median age, 70 years) were retrospectively analyzed. Carotid arteries were studied with a multienergy CT scanner. All patients received a 15-mL timing bolus of contrast medium to synchronize the data acquisition followed by an injection of 60 mL of contrast medium at a 5-mL/s flow rate. Plaque analysis in 64 carotid arteries was performed, and datasets were reconstructed by using a dedicated workstation. For each plaque, the HU value was quantified with a 2-mm-square region of interest at monoenergy values of 66, 70, 77, and 86 keV. The Wilcoxon test was used to test the differences in HU values in the plaques at different kiloelectron volts. RESULTS: Four carotid arteries were excluded due to the absence of plaque, and another 7, because of the presence of calcified plaques. In the remaining 53 carotid arteries, Wilcoxon analysis showed a statistically significant difference in HU values among the monoenergy values of 66, 70, 77, and 86 keV (P=.0001). In particular, we found that with the increase in monochromatic kiloelectron volt values, there is a statistically significant reduction in the HU value of the plaque. CONCLUSIONS: Results of this study suggest that the HU values of plaque may significantly change according to the selected kiloelectron volt; therefore, the HU-based plaque type (fatty, mixed, calcified) should be classified according to the energy level applied.

Comparison of MRI, EEG, EPs and ECD-SPECT in Wilson's disease.

OBJECTIVES: The purpose of this study is to evaluate the efficiency of a few methodologies in detecting anatomo-functional brain abnormalities in patients with Wilson's disease. MATERIALS AND METHODS: Twenty-three patients with Wilson's disease underwent almost simultaneously brain magnetic resonance imaging (MRI), computerized electroencephalography (EEG), multimodal evoked potentials (EPs) and ECD single photon computerized tomography (SPECT) evaluation. The clinical picture was of the neurologic type in 8 patients and of the hepatic type in 15. RESULTS: MRI was abnormal in 7 patients with neurological manifestations. The EPs proved pathologic in 7 neurologically symptomatic patients and in 4 cases with hepatic form. These results agree with those reported in other case studies. The EEG records were abnormal only in 3 cases. Nevertheless, the most interesting finding of this study is the particular frequency (86%) of diffuse or focal decrease of ECD uptake shown by brain SPECT. CONCLUSION: We highlight the use of this interesting procedure in the therapeutic monitoring of this disease.